Phase II Study Of Combination Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Ruxolitinib (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Breast cancer
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 27 Apr 2017 Status changed from not yet recruiting to recruiting.
- 01 Mar 2017 Planned initiation date changed from 1 Aug 2016 to 1 Mar 2017.